FDA gives approval for more research into deep brain stimulation for Alzheimer’s
More geriatricians essential to treat boomer’s mental health issues

Experimental Alzheimer’s drug slows cognitive decline dramatically in some people

A small study using an experimental drug designed to slow the progress of Alzheimer’s disease has proven to be quite successful, so far. CBS News reported that the drug, called IVIG, contains antibodies from people who don't have Alzheimer's. It appears that the drug attacks Amyloid, the plaque that is thought to damage the brain. At this time, the Amyloid plaque is considered the hallmark of Alzheimer's disease. 

The study showed that IVIG actually halted the cognitive decline in some patients with diagnosed AD. Twenty-four patients were studied, with 11 showing a smaller decline than the group taking a placebo. However, four patients showed no decline.

Read more about the experimental drug that may dramatically slow cognitive decline in Alzheimer's:

Purchase Minding Our Elders: Caregivers Share Their Personal Stories – paperback or ebook


Feed You can follow this conversation by subscribing to the comment feed for this post.

This is good information! At least there is progress and faith to know there may be hope.

I agree, Sue. At this time the studies simply mean that research is going on. This study is too small to have a lot of value, however with four people having a dramatic turnaround and 11 doing better, that has some significance. As the article said, this is way to far ahead for us to get too excited. But we do watch studies because one day there may be something really significant.

What I don't understand is why they don't do more work on insulin, which has shown great promise. That is available now. Likely people are working hard on it, but I'd really love to hear about a huge study on insulin for AD.
Take care,

I know seeing these types of success stories always brings hope, and I hope this is truly a drug that can make a difference, but I wonder about studies that are not double blind and contain such a small group of participants. Do they really have any scientific value? I am glad for the emotional value, but I wonder if they really mean anything.

Thanks for sharing! It's good to hear information like this. Alzheimer's is such a horrible disease, we can only hope that some progress is really being made. Even if it is just a small step, it's definitely a step in the right direction. Thanks again.

The comments to this entry are closed.